Jeremias Antinew

Abrocitinib versus Placebo or Dupilumab for Atopic Dermatitis

Thomas Bieber, Eric L. Simpson, Jonathan I. Silverberg et al. · New England Journal of Medicine · 2021 · 419 citations · Full text

Pregabalin as Adjunctive Treatment for Focal Onset Seizures in Pediatric Patients: A Randomized Controlled Trial

Jeremias Antinew, B. Pitrosky, Lloyd Knapp et al. · Journal of Child Neurology · 2019 · 17 citations

Pregabalin adjunctive therapy for focal onset seizures in children 1 month to <4 years of age: A double‐blind, placebo‐controlled, video‐electroencephalographic trial

Donald W. Mann, Jeremias Antinew, Lloyd Knapp et al. · Epilepsia · 2020 · 17 citations

Leveraging Prior Healthy Participant Pharmacokinetic Data to Evaluate the Impact of Renal and Hepatic Impairment on Ritlecitinib Pharmacokinetics

Vivek S. Purohit, Yeamin Huh, Jessica Wojciechowski et al. · The AAPS Journal · 2023 · 12 citations · Full text

P3‐361: A randomized, double‐blind, sponsor‐unblinded, placebo‐ and positive‐controlled study to evaluate the effects of single oral administrations of PF‐04995274 on scopolamine‐induced deficits in cognitive function in healthy adults

Claire Leurent, Sridhar Duvvuri, David Raunig et al. · Alzheimer s & Dementia · 2012 · 10 citations

Healthy Subjects, Psychopharmacology, Scopolamine Deficit +20